A.R.T. Advisors’s Q32 Bio QTTB Stock Holding History

A.R.T. Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,355	Closed	-$505K	–	1026
2019 Q4	$505K	Buy	+1,355	New	+$388K	0.02%	852
2019 Q3	–	Sell	-849	Closed	-$299K	–	1771
2019 Q2	$299K	Buy	+849	New	+$334K	0.02%	958

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

A.R.T. Advisors's QTTB Position: Q1 2020 in Review

A.R.T. Advisors sold out of Q32 Bio (QTTB) in Q1 2020, closing a stake of 1,355 shares — an estimated $505K sold.

A.R.T. Advisors first reported a position in QTTB in Q2 2019 and held it in 2 quarters. The position peaked at $505K in Q4 2019. 91 funds tracked by Wall St. Rank hold QTTB as of Q1 2020.

A.R.T. Advisors reported no remaining Q32 Bio position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 1,355 Q32 Bio shares in Q1 2020, an estimated $505K.
A.R.T. Advisors first reported a position in Q32 Bio in Q2 2019 and held it in 2 quarters.
A.R.T. Advisors's Q32 Bio position peaked at $505K in Q4 2019.
91 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.